Patient randomised controlled trial of technology enabled strategies to promote treatment adherence in liver transplantation: rationale and design of the TEST trial

Keyphrases

• Transplant Center 100%
• Liver Transplantation 100%
• Treatment Adherence 100%
• Technology Support 100%
• Randomized Controlled Trial 100%
• Medication Adherence 100%
• Non-adherence 100%
• Quality of Life 50%
• Health Outcomes 50%
• Usual Care 50%
• Ethics 50%
• Improved Outcomes 50%
• Lifesaving 50%
• Immunosuppression 50%
• End-stage Liver Disease 50%
• Clinical Outcomes 50%
• Text Messaging 50%
• Cost-effectiveness 50%
• Midwest 50%
• Tacrolimus 50%
• Peer-reviewed Journals 50%
• Review Board 50%
• Adverse Consequences 50%
• Self-management Support 50%
• University of Pennsylvania 50%
• Graft Rejection 50%
• Medication Regimen 50%
• Clinical Staff 50%
• Functional Health Status 50%
• Single IRB 50%
• Knowledge Scale 50%
• Trial Registration 50%
• Randomized Prospective Clinical Trial 50%
• Medical Regimen 50%
• Medication Nonadherence 50%
• 24-hour Recall 50%
• Self-report Scale 50%
• Adherence Monitoring 50%
• Digital Health Application 50%

Nursing and Health Professions

• Patient Compliance 100%
• Medication Compliance 100%
• Liver Transplantation 100%
• Clinical Outcome 50%
• Quality of Life 50%
• Cost Effectiveness Analysis 50%
• Self Care 50%
• Patient Monitor 50%
• Health Status 50%
• End Stage Liver Disease 50%
• Immunosuppressive Treatment 50%
• Graft Rejection 50%
• Tacrolimus 50%